04/03/2012 Members of OCRF’s senior staff and Scientific Advisory Committee recently attended the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer in Austin, TX. Now in its 43rd year, the Annual Meeting on Women’s Cancer continues to be the premier educational activity for women’s cancer care professionals. Data Confirm PARP Inhibitor Slows Ovarian … Continued
03/06/2012 The U.S. Preventive Services Task Force (USPSTF), an independent volunteer panel of non-government experts in prevention and evidence-based medicine, is composed of primary care providers (such as internists, pediatricians, family physicians, gynecologists/obstetricians, and nurses). This prestigious group conducts rigorous scientific reviews of a broad range of clinical preventive health care services (such as screening, counseling, … Continued
02/22/2012 Research by a team of scientists funded by OCRF has shown that there is an association between invasive ovarian cancer and endometriosis. The research was reported on February 22nd in Lancet Oncology. The Ovarian Cancer Association Consortium, a collaborative created with the support of OCRF and led by grantee Dr. Andrew Berchuck, conducted an analysis … Continued
02/17/2012 An international team of researchers led by OCRF grantee Anil Sood, MD has found that elevated platelet levels in ovarian cancer patients fuel tumor growth and reduce survival. These findings reveal a new factor in cancer progression and a possible new approach for treatment. The study, which was reported in the New England Journal of Medicine, was … Continued
02/16/2012 Work funded by Ovarian Cancer Research Fund has shown that the high-grade serous ovarian cancer arises in the fallopian tube of mice that lack two specific genes. The report appeared online this week in the journal Proceedings of the National Academy of Sciences. Little is known about how ovarian cancer starts and spreads. Recent … Continued
01/27/2012 A large, multicenter study shows that women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes have better survival rates than women who do not have such mutations. The study is also the first to provide strong evidence that ovarian cancer prognosis is better for women with BRCA2 mutations than … Continued
01/24/2012 The use of symptom indices to identify patients with symptoms associated with ovarian cancer who may need further screening is increasing in both the UK and the US in an attempt to promote earlier diagnosis, but these indices may need to be reassessed in order to help better detect cancer, according to a study … Continued
01/20/2012 Dr. Doug Levine and Dr. Carol Aghajanian, both recipients of OCRF grants, were part of a project recently published in Cancer Discovery that studied AKT inhibition in ovarian cancer cell lines with various mechanisms of AKT pathway activation. Researchers found that some cell lines were responsive to AKT inhibitors, but depended greatly on other, co-existent, … Continued
OCRF has awarded $5.4 million in grants for ovarian cancer research this year. After receiving over 100 applications – the highest number in its history – OCRF and its prestigious Scientific Advisory Committee endeavored first and foremost to fund the best science. The Committee evaluated each proposal through intensive peer review, and selected a sound … Continued
OCRF receives record number of grant applications; continues to fund the best science New York, NY January 3, 2012— Ovarian Cancer Research Fund (OCRF) has awarded $5.4 million in grants for ovarian cancer research this year. After receiving over 100 applications – the highest number in its history – OCRF and its prestigious Scientific Advisory … Continued
08/17/2011Researchers in the United Kingdom have discovered a new genetic mutation that increases the risk for ovarian cancer. This major finding was published online in the journal Nature Genetics on August 7th. Much like the BRCA1 and BRCA2 mutations, which were discovered in the 1990s and which also increase a woman’s risk for ovarian cancer, … Continued
In a paper published on June 30, 2011 in the journal Nature, researchers working as part of The Cancer Genome Atlas (TCGA) Research Network report that they have created a genetic “map” of ovarian cancer. This important work, which is the largest study of any tumor type to date, will help researchers better understand the … Continued
Get email updates about research news, action alerts, and ways to join the fight.
